138 related articles for article (PubMed ID: 22328006)
1. Fenoterol enantiomers do not possess beneficial therapeutic properties of their racemic mixture in the rat model of post myocardial infarction dilated cardiomyopathy.
Ahmet I; Turner T; Lakatta EG; Talan MI
Cardiovasc Drugs Ther; 2012 Apr; 26(2):101-8. PubMed ID: 22328006
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.
Ahmet I; Morrell C; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
Ahmet I; Tae HJ; Brines M; Cerami A; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2013 Jun; 345(3):446-56. PubMed ID: 23584743
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
[TBL] [Abstract][Full Text] [Related]
8. β₂ AR agonists in treatment of chronic heart failure: long path to translation.
Talan MI; Ahmet I; Xiao RP; Lakatta EG
J Mol Cell Cardiol; 2011 Oct; 51(4):529-33. PubMed ID: 20888833
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling.
Kubin T; Pöling J; Kostin S; Gajawada P; Hein S; Rees W; Wietelmann A; Tanaka M; Lörchner H; Schimanski S; Szibor M; Warnecke H; Braun T
Cell Stem Cell; 2011 Nov; 9(5):420-32. PubMed ID: 22056139
[TBL] [Abstract][Full Text] [Related]
12. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
Rinaldi B; Donniacuo M; Sodano L; Gritti G; Martuscelli E; Orlandi A; Rafaniello C; Rossi F; Calzetta L; Capuano A; Matera MG
Br J Pharmacol; 2015 Jul; 172(14):3627-37. PubMed ID: 25825265
[TBL] [Abstract][Full Text] [Related]
14. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model.
Isobe K; Kuba K; Maejima Y; Suzuki J; Kubota S; Isobe M
Circ J; 2010 Jan; 74(1):109-19. PubMed ID: 19966499
[TBL] [Abstract][Full Text] [Related]
16. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
Sandmann S; Bohle RM; Dreyer T; Unger T
Virchows Arch; 2000 Feb; 436(2):147-57. PubMed ID: 10755606
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin octapeptide reduces myocardial fibrosis and improves cardiac remodeling in post myocardial infarction rats.
Wang C; Zhang C; Wu D; Guo L; Zhao F; Lv J; Fu L
Int J Biochem Cell Biol; 2020 Aug; 125():105793. PubMed ID: 32554056
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
19. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
Yang Y; Rong X; Lv X; Jiang W; Yang Y; Lai D; Xu S; Fu G
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]